Effectiveness and Safety of Direct Oral Anticoagulants versus Aspirin in Patients with Non-Valvular Atrial Fibrillation and Intermediate Stroke Risk
Clinical and Applied Thrombosis/Hemostasis
Published online on January 20, 2026
Abstract
Clinical and Applied Thrombosis/Hemostasis, Volume 32, January-December 2026.
AimsThis study compared the effectiveness and safety of direct oral anticoagulants (DOACs) versus aspirin for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) and intermediate stroke risk, defined by a CHA2DS2-VASc score of 1 in ...
AimsThis study compared the effectiveness and safety of direct oral anticoagulants (DOACs) versus aspirin for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) and intermediate stroke risk, defined by a CHA2DS2-VASc score of 1 in ...